Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 183624, 9 pages
http://dx.doi.org/10.1155/2015/183624
Research Article

Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer

1Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Huzhou, Zhejiang 313000, China
2Cardiothoracic Surgery, Huzhou Central Hospital, Huzhou, Zhejiang 313000, China
3Respiratory Medicine, Huzhou Central Hospital, Huzhou, Zhejiang 313000, China
4School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

Received 11 February 2015; Revised 23 March 2015; Accepted 27 March 2015

Academic Editor: Xin-yuan Guan

Copyright © 2015 Yingrong Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Molina, J. M. Auge, J. M. Escudero et al., “Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE,” Tumor Biology, vol. 29, no. 6, pp. 371–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Xue, Z. Lin, C. Deng et al., “A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 22, no. 19, pp. 3061–3068, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Bogdanov, W. R. Matson, L. Wang et al., “Metabolomic profiling to develop blood biomarkers for Parkinson's disease,” Brain, vol. 131, no. 2, pp. 389–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W. M. Claudino, A. Quattrone, L. Biganzoli, M. Pestrin, I. Bertini, and A. Di Leo, “Metabolomics: available results, current research projects in breast cancer, and future applications,” Journal of Clinical Oncology, vol. 25, no. 19, pp. 2840–2846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W. R. Wikoff, J. A. Gangoiti, B. A. Barshop, and G. Siuzdak, “Metabolomics identifies perturbations in human disorders of propionate metabolism,” Clinical Chemistry, vol. 53, no. 12, pp. 2169–2176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. K. Nicholson, J. Connelly, J. C. Lindon, and E. Holmes, “Metabonomics: a platform for studying drug toxicity and gene function,” Nature Reviews Drug Discovery, vol. 1, no. 2, pp. 153–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Li, H. Liu, Y. Jin, S. Lin, Z. Cai, and Y. Jiang, “Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 24, pp. 2369–2375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. V. W.-S. Wong, G. L.-H. Wong, W. C.-W. Chu et al., “Hepatitis B virus infection and fatty liver in the general population,” Journal of Hepatology, vol. 56, no. 3, pp. 533–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Zhang, H. Sun, and X. Wang, “Power of metabolomics in biomarker discovery and mining mechanisms of obesity,” Obesity Reviews, vol. 14, no. 4, pp. 344–349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-H. Chen, B. M. Enloe, C. D. Fletcher, D. G. Cory, and S. Singer, “Biochemical analysis using high-resolution magic angle spinning NMR spectroscopy distinguishes lipoma-like well-differentiated liposarcoma from normal fat,” Journal of the American Chemical Society, vol. 123, no. 37, pp. 9200–9201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Chen, W. Wang, S. Lv et al., “Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations,” Analytica Chimica Acta, vol. 650, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. K. Pasikanti, P. C. Ho, and E. C. Y. Chan, “Gas chromatography/mass spectrometry in metabolic profiling of biological fluids,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 871, no. 2, pp. 202–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Chen, Z. Ma, A. Li et al., “Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 4, pp. 705–718, 2015. View at Publisher · View at Google Scholar
  15. E. G. Armitage and C. Barbas, “Metabolomics in cancer biomarker discovery: current trends and future perspectives,” Journal of Pharmaceutical and Biomedical Analysis, vol. 87, pp. 1–11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Ganter, N. Zidek, P. R. Hewitt, D. Müller, and A. Vladimirova, “Pathway analysis tools and toxicogenomics reference databases for risk assessment,” Pharmacogenomics, vol. 9, no. 1, pp. 35–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Saddoughi, P. Song, and B. Ogretmen, “Roles of bioactive sphingolipids in cancer biology and therapeutics,” in Lipids in Health and Disease, vol. 49 of Subcellular Biochemistry, pp. 413–440, Springer, Amsterdam, The Netherlands, 2008. View at Publisher · View at Google Scholar
  18. O. Cuvillier, “Downregulating sphingosine kinase-1 for cancer therapy,” Expert Opinion on Therapeutic Targets, vol. 12, no. 8, pp. 1009–1020, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Yu, Q. Wu, W. Lu et al., “Metabonomics study of lung cancer cells based on liquid chromatography-mass spectrometry,” Se Pu, vol. 31, no. 7, pp. 691–696, 2013. View at Google Scholar
  20. D. R. Sagar, A. G. Gaw, B. N. Okine et al., “Dynamic regulation of the endocannabinoid system: implications for analgesia,” Molecular Pain, vol. 5, article 59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Mechoulam, E. Fride, and V. D. Marzo, “Endocannabinoids,” European Journal of Pharmacology, vol. 359, no. 1, pp. 1–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Guzmán and C. Sánchez, “Effects of cannabinoids on energy metabolism,” Life Sciences, vol. 65, no. 6-7, pp. 657–664, 1999. View at Publisher · View at Google Scholar · View at Scopus